Literature DB >> 2723638

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

D T Dexter1, F R Wells, A J Lees, F Agid, Y Agid, P Jenner, C D Marsden.   

Abstract

Levels of iron, copper, zinc, manganese, and lead were measured by inductively coupled plasma spectroscopy in parkinsonian and age-matched control brain tissue. There was 31-35% increase in the total iron content of the parkinsonian substantia nigra when compared to control tissue. In contrast, in the globus pallidus total iron levels were decreased by 29% in Parkinson's disease. There was no change in the total iron levels in any other region of the parkinsonian brain. Total copper levels were reduced by 34-45% in the substantia nigra in Parkinson's disease; no difference was found in the other brain areas examined. Zinc levels were increased in substantia nigra in Parkinson's disease by 50-54%, and the zinc content of the caudate nucleus and lateral putamen was also raised by 18-35%. Levels of manganese and lead were unchanged in all areas of the parkinsonian brain studied when compared to control brains, except for a small decrease (20%) in manganese content of the medial putamen. Increased levels of total iron in the substantia nigra may cause the excessive formation of toxic oxygen radicals, leading to dopamine cell death.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723638     DOI: 10.1111/j.1471-4159.1989.tb07264.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  245 in total

1.  Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

Authors:  R Pedrosa; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Ferritin in the cerebrospinal fluid of patients with Parkinson's disease.

Authors:  H S Pall; S Brailsford; A C Williams; J Lunec; D R Blake
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

Review 3.  The modern management of Parkinson's disease.

Authors:  N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

4.  Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells.

Authors:  Wen-Jing Li; Hong Jiang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

5.  Concerted action of metals and macromolecular crowding on the fibrillation of alpha-synuclein.

Authors:  Larissa A Munishkina; Anthony L Fink; Vladimir N Uversky
Journal:  Protein Pept Lett       Date:  2008       Impact factor: 1.890

6.  Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.

Authors:  Guangwei Du; Mechelle M Lewis; Christopher Sica; Lu He; James R Connor; Lan Kong; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

7.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

8.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.

Authors:  Yong Peng; Chengshan Wang; Howard H Xu; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2009-11-18       Impact factor: 4.155

9.  Lazaroids improve the survival of grafted rat embryonic dopamine neurons.

Authors:  N Nakao; E M Frodl; W M Duan; H Widner; P Brundin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.